Virtual Medicinal Product (VMP)
-
Ceftazidime 500mg powder for solution for injection vials
Name Details
Current Name
Ceftazidime 500mg powder for solution for injection vials
|
Start Date
25-06-2004
|
End Date
|
Previous Name
Ceftazidime 500mg injection vials
|
Start Date
13-05-2003
|
End Date
24-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, solutioninjection.intramuscular-deep, solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01DD02
BNF |
Current BNF
05010201
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010201
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
05010200
|
Start Date
01-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41945211000001100 |
09-06-2023 |
|
323853003 |
13-05-2003 |
08-06-2023 |
VMP Ingredients
Name
Ceftazidime pentahydrate
Basis of strength description
Based on Base Substance
BOSS
Ceftazidime
Strength and UOM (Nmr)
500
Strength and UOM (Dmr)
Parent Products
-
VTM
Ceftazidime
-
VMP
(Current) Ceftazidime 500mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information